Informazioni sul dominio e sul sito Web:
avacopan.it
Nome del dominio - avacopan.it
Titolo del sito - Future home of avacopan.it
Vai al sito web - Future home of avacopan.it
Posizione GEO del sito
Posizione Paese - Canada
Paese di registrazione - United States
Città /Paese - Montreal
Fornitore - AMAZON-02
Site Logo
indirizzo IP:
Server dei nomi di dominio:
ns5.101domain.com ns2.101domain.com ns1.101domain.com
Tutti i record:
☆ avacopan.it. 3789 IN HINFO "RFC8482" ""
Brief facts about avacopan:
Avacopan, sold under the brand name Tavneos, is a medication used to treat anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Avacopan is a complement 5a receptor antagonist and a cytochrome P450 3A4 inhibitor. The most common side effects include nausea, headache, decrease in white blood cell count, upper respiratory tract infection, diarrhea, vomiting, and nasopharyngitis. Avacopan was approved for medical use in Japan in September 2021, and in the United States in October 2021. It is the first orally-administered inhibitor of the complement C5a receptor approved by the US Food and Drug Administration. The FDA considers it to be a first-in-class medication.
© DMS 2011-